{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:08:23Z","timestamp":1790093303850,"version":"4.0.1"},"reference-count":158,"publisher":"Aging and Disease","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2020]]},"DOI":"10.14336\/ad.2020.0216","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T12:09:10Z","timestamp":1605960550000},"page":"1608","source":"Crossref","is-referenced-by-count":129,"title":["The Critical Role of SIRT1 in Parkinson\u2019s Disease: Mechanism and Therapeutic Considerations"],"prefix":"10.14336","volume":"11","author":[{"given":"Xuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Xi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Truong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Cheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2020.0216-1","doi-asserted-by":"crossref","unstructured":"Chahine LM, Amara AW, Videnovic A (2017). A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015. Sleep Med Rev, 35:33-50.","DOI":"10.1016\/j.smrv.2016.08.001"},{"key":"key-10.14336\/AD.2020.0216-2","doi-asserted-by":"crossref","unstructured":"Maloney EM, Djamshidian A, O'Sullivan SS (2017). Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations. J Neurol Sci, 374:47-52.","DOI":"10.1016\/j.jns.2016.12.058"},{"key":"key-10.14336\/AD.2020.0216-3","doi-asserted-by":"crossref","unstructured":"Johnson S, Imai SI (2018). NAD (+) biosynthesis, aging, and disease. F1000Res, 7:132.","DOI":"10.12688\/f1000research.12120.1"},{"key":"key-10.14336\/AD.2020.0216-4","doi-asserted-by":"crossref","unstructured":"Khan SA, Sathyanarayan A, Mashek MT, Ong KT, Wollaston-Hayden EE, Mashek DG (2015). ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1alpha\/PPAR-alpha signaling. Diabetes, 64:418-426.","DOI":"10.2337\/db14-0325"},{"key":"key-10.14336\/AD.2020.0216-5","doi-asserted-by":"crossref","unstructured":"Shekhar S, Yadav Y, Singh AP, Pradhan R, Desai GR, Dey AB, et al. (2018). Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway. Exp Gerontol, 110:277-283.","DOI":"10.1016\/j.exger.2018.06.026"},{"key":"key-10.14336\/AD.2020.0216-6","doi-asserted-by":"crossref","unstructured":"Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A (2013). Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal, 25:1939-1948.","DOI":"10.1016\/j.cellsig.2013.06.007"},{"key":"key-10.14336\/AD.2020.0216-7","doi-asserted-by":"crossref","unstructured":"Kupis W, Palyga J, Tomal E, Niewiadomska E (2016). The role of sirtuins in cellular homeostasis. J Physiol Biochem, 72:371-380.","DOI":"10.1007\/s13105-016-0492-6"},{"key":"key-10.14336\/AD.2020.0216-8","doi-asserted-by":"crossref","unstructured":"Corpas R, Revilla S, Ursulet S, Castro-Freire M, Kaliman P, Petegnief V, et al. (2017). SIRT1 overexpression in mouse hippocampus induces cognitive enhancement through proteostatic and neurotrophic mechanisms. Mol Neurobiol, 54:5604-5619.","DOI":"10.1007\/s12035-016-0087-9"},{"key":"key-10.14336\/AD.2020.0216-9","doi-asserted-by":"crossref","unstructured":"Herskovits AZ, Guarente L (2014). SIRT1 in neurodevelopment and brain senescence. Neuron, 81:471-483.","DOI":"10.1016\/j.neuron.2014.01.028"},{"key":"key-10.14336\/AD.2020.0216-10","doi-asserted-by":"crossref","unstructured":"Donmez G, Outeiro TF (2013). SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol Med, 5:344-352.","DOI":"10.1002\/emmm.201302451"},{"key":"key-10.14336\/AD.2020.0216-11","doi-asserted-by":"crossref","unstructured":"Kaeberlein M, McVey M, Guarente L (1999). The SIR2\/3\/4 complex and SIR2 alone promote longevity in saccharomyces cerevisiae by two different mechanisms. Genes Dev, 13:2570-2580.","DOI":"10.1101\/gad.13.19.2570"},{"key":"key-10.14336\/AD.2020.0216-12","doi-asserted-by":"crossref","unstructured":"Satoh A, Brace CS, Rensing N, Cliften P, Wozniak DF, Herzog ED, et al. (2013). SIRT1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab, 18:416-430.","DOI":"10.1016\/j.cmet.2013.07.013"},{"key":"key-10.14336\/AD.2020.0216-13","doi-asserted-by":"crossref","unstructured":"Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y (2007). Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem, 282:6823-6832.","DOI":"10.1074\/jbc.M609554200"},{"key":"key-10.14336\/AD.2020.0216-14","doi-asserted-by":"crossref","unstructured":"Polak-Jonkisz D, Laszki-Szcza\u00b8chor K, Rehan L, Pilecki W, Filipowski H, Sobieszcza\u0144ska M (2013). Nephroprotective action of sirtuin 1 (SIRT1). J Physiol Biochem, 69:957-961.","DOI":"10.1007\/s13105-013-0268-1"},{"key":"key-10.14336\/AD.2020.0216-15","doi-asserted-by":"crossref","unstructured":"Favero G, Franceschetti L, Rodella LF, Rezzani R (2015). Sirtuins, aging, and cardiovascular risks. Age (Dordr), 37:9804.","DOI":"10.1007\/s11357-015-9804-y"},{"key":"key-10.14336\/AD.2020.0216-16","doi-asserted-by":"crossref","unstructured":"Zhao L, Liu H, Yue L, Zhang J, Li X, Wang B, et al. (2017). Melatonin attenuates early brain injury via the melatonin receptor\/SIRT1\/NF-kappaB signaling pathway following subarachnoid hemorrhage in mice. Mol Neurobiol, 54:1612-1621.","DOI":"10.1007\/s12035-016-9776-7"},{"key":"key-10.14336\/AD.2020.0216-17","doi-asserted-by":"crossref","unstructured":"Feng S, Li M, Zhang J, Liu S, Wang Q, Quan M, et al. (2015). Regulation of HepG2 cell apoptosis by hepatitis C virus (HCV) core protein via the sirt1-p53-bax pathway. Virus Genes, 51:338-346.","DOI":"10.1007\/s11262-015-1253-2"},{"key":"key-10.14336\/AD.2020.0216-18","doi-asserted-by":"crossref","unstructured":"Wang WR, Li TT, Jing T, Li YX, Yang XF, He YH, et al. (2017). SIRT1 regulates the inflammatory response of vascular adventitial fibroblasts through autophagy and related signaling pathway. Cell Physiol Biochem, 41:569-582.","DOI":"10.1159\/000457878"},{"key":"key-10.14336\/AD.2020.0216-19","doi-asserted-by":"crossref","unstructured":"Said RS, El-Demerdash E, Nada AS, Kamal MM (2016). Resveratrol inhibits inflammatory signaling implicated in ionizing radiation-induced premature ovarian failure through antagonistic crosstalk between silencing information regulator 1 (SIRT1) and poly(ADP-ribose) polymerase 1 (PARP-1). Biochem Pharmacol, 103:140-150.","DOI":"10.1016\/j.bcp.2016.01.019"},{"key":"key-10.14336\/AD.2020.0216-20","doi-asserted-by":"crossref","unstructured":"Chan SH, Chu PM, Kao CL, Cheng YH, Hung CH, Tsai KL (2016). Oleic acid activates MMPs up-regulation through SIRT1\/PPAR-gamma inhibition: a probable linkage between obesity and coronary arterial disease. J Biochem, 160:217-225.","DOI":"10.1093\/jb\/mvw028"},{"key":"key-10.14336\/AD.2020.0216-21","doi-asserted-by":"crossref","unstructured":"Zhang T, Chi Y, Ren Y, Du C, Shi Y, Li Y (2019). Resveratrol reduces oxidative stress and apoptosis in podocytes via Sir2-related enzymes, sirtuins1 (SIRT1)\/peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) Axis. Med Sci Monit, 25:1220-1231.","DOI":"10.12659\/MSM.911714"},{"key":"key-10.14336\/AD.2020.0216-22","doi-asserted-by":"crossref","unstructured":"Wang A, Li T, An P, Yan W, Zheng H, Wang B, et al. (2017). Exendin-4 upregulates adiponectin level in adipocytes via Sirt1\/Foxo-1 signaling pathway. PLoS One, 12:e0169469.","DOI":"10.1371\/journal.pone.0169469"},{"key":"key-10.14336\/AD.2020.0216-23","doi-asserted-by":"crossref","unstructured":"Reverchon M, Rame C, Bunel A, Chen W, Froment P, Dupont J (2016). VISFATIN (NAMPT) improves in vitro IGF1-induced steroidogenesis and IGF1 receptor signaling through SIRT1 in bovine granulosa cells. Biol Reprod, 94:54.","DOI":"10.1095\/biolreprod.115.134650"},{"key":"key-10.14336\/AD.2020.0216-24","doi-asserted-by":"crossref","unstructured":"Ren JH, Tao Y, Zhang ZZ, Chen WX, Cai XF, Chen K, et al. (2014). Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1. J Virol, 88:2442-2451.","DOI":"10.1128\/JVI.02861-13"},{"key":"key-10.14336\/AD.2020.0216-25","doi-asserted-by":"crossref","unstructured":"Dong SY, Guo YJ, Feng Y, Cui XX, Kuo SH, Liu T, et al. (2016). The epigenetic regulation of HIF-1alpha by SIRT1 in MPP(+) treated SH-SY5Y cells. Biochem Biophys Res Commun, 470:453-459.","DOI":"10.1016\/j.bbrc.2016.01.013"},{"key":"key-10.14336\/AD.2020.0216-26","doi-asserted-by":"crossref","unstructured":"Skoge RH, Dolle C, Ziegler M (2014). Regulation of SIRT2-dependent alpha-tubulin deacetylation by cellular NAD levels. DNA Repair (Amst), 23:33-38.","DOI":"10.1016\/j.dnarep.2014.04.011"},{"key":"key-10.14336\/AD.2020.0216-27","doi-asserted-by":"crossref","unstructured":"Huang H, Zhang D, Wang Y, Perez-Neut M, Han Z, Zheng YG, et al. (2018). Lysine benzoylation is a histone mark regulated by SIRT2. Nat Commun, 9:3374.","DOI":"10.1038\/s41467-018-05567-w"},{"key":"key-10.14336\/AD.2020.0216-28","doi-asserted-by":"crossref","unstructured":"Cui XX, Li X, Dong SY, Guo YJ, Liu T, Wu YC (2017). SIRT3 deacetylated and increased citrate synthase activity in PD model. Biochem Biophys Res Commun, 484:767-773.","DOI":"10.1016\/j.bbrc.2017.01.163"},{"key":"key-10.14336\/AD.2020.0216-29","doi-asserted-by":"crossref","unstructured":"Tseng AH, Wu LH, Shieh SS, Wang DL (2014). SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia. Biochem J, 464:157-168.","DOI":"10.1042\/BJ20140213"},{"key":"key-10.14336\/AD.2020.0216-30","doi-asserted-by":"crossref","unstructured":"Mu HN, Li Q, Pan CS, Liu YY, Yan L, Hu BH, et al. (2015). Caffeic acid attenuates rat liver reperfusion injury through sirtuin 3-dependent regulation of mitochondrial respiratory chain. Free Radic Biol Med, 85:237-249.","DOI":"10.1016\/j.freeradbiomed.2015.04.033"},{"key":"key-10.14336\/AD.2020.0216-31","doi-asserted-by":"crossref","unstructured":"Luo K, Huang W, Tang S (2018). Sirt3 enhances glioma cell viability by stabilizing Ku70-BAX interaction. Onco Targets Ther, 11:7559-7567.","DOI":"10.2147\/OTT.S172672"},{"key":"key-10.14336\/AD.2020.0216-32","doi-asserted-by":"crossref","unstructured":"Laurent G, German NJ, Saha AK, de Boer VC, Davies M, Koves TR, et al. (2013). SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Mol Cell, 50:686-698.","DOI":"10.1016\/j.molcel.2013.05.012"},{"key":"key-10.14336\/AD.2020.0216-33","doi-asserted-by":"crossref","unstructured":"Polletta L, Vernucci E, Carnevale I, Arcangeli T, Rotili D, Palmerio S, et al. (2015). SIRT5 regulation of ammonia-induced autophagy and mitophagy. Autophagy, 11:253-270.","DOI":"10.1080\/15548627.2015.1009778"},{"key":"key-10.14336\/AD.2020.0216-34","doi-asserted-by":"crossref","unstructured":"Nakagawa T, Lomb DJ, Haigis MC, Guarente L (2009). SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell, 137:560-570.","DOI":"10.1016\/j.cell.2009.02.026"},{"key":"key-10.14336\/AD.2020.0216-35","doi-asserted-by":"crossref","unstructured":"Yang Z, Yu W, Huang R, Ye M, Min Z (2019). SIRT6\/HIF-1alpha axis promotes papillary thyroid cancer progression by inducing epithelial-mesenchymal transition. Cancer Cell Int, 19:17.","DOI":"10.1186\/s12935-019-0730-4"},{"key":"key-10.14336\/AD.2020.0216-36","doi-asserted-by":"crossref","unstructured":"Lin Z, Yang H, Tan C, Li J, Liu Z, Quan Q, et al. (2013). USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation. Cell Rep, 5:1639-1649.","DOI":"10.1016\/j.celrep.2013.11.029"},{"key":"key-10.14336\/AD.2020.0216-37","doi-asserted-by":"crossref","unstructured":"Tong Z, Wang M, Wang Y, Kim DD, Grenier JK, Cao J, et al. (2017). SIRT7 is an RNA-activated protein lysine deacylase. ACS Chem Biol, 12:300-310.","DOI":"10.1021\/acschembio.6b00954"},{"key":"key-10.14336\/AD.2020.0216-38","doi-asserted-by":"crossref","unstructured":"Sun M, Zhai M, Zhang N, Wang R, Liang H, Han Q, et al. (2018). MicroRNA-148b-3p is involved in regulating hypoxia\/reoxygenation-induced injury of cardiomyocytes in vitro through modulating SIRT7\/p53 signaling. Chem Biol Interact, 296:211-219.","DOI":"10.1016\/j.cbi.2018.10.003"},{"key":"key-10.14336\/AD.2020.0216-39","doi-asserted-by":"crossref","unstructured":"Kalia LV, Lang AE (2015). Parkinson's disease. Lancet, 386:896-912.","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"key-10.14336\/AD.2020.0216-40","doi-asserted-by":"crossref","unstructured":"Benskey MJ, Perez RG, Manfredsson FP (2016). The contribution of alpha synuclein to neuronal survival and function - implications for Parkinson's disease. J Neurochem, 137:331-359.","DOI":"10.1111\/jnc.13570"},{"key":"key-10.14336\/AD.2020.0216-41","doi-asserted-by":"crossref","unstructured":"Olanow CW, Brundin P (2013). Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Mov Disord, 28:31-40.","DOI":"10.1002\/mds.25373"},{"key":"key-10.14336\/AD.2020.0216-42","doi-asserted-by":"crossref","unstructured":"Koronowski KB, Perez-Pinzon MA (2015). Sirt1 in cerebral ischemia. Brain Circ, 1:69-78.","DOI":"10.4103\/2394-8108.162532"},{"key":"key-10.14336\/AD.2020.0216-43","doi-asserted-by":"crossref","unstructured":"Zakhary SM, Ayubcha D, Dileo JN, Jose R, Leheste JR, Horowitz JM, et al. (2010). Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems. Anat Rec (Hoboken), 293:1024-1032.","DOI":"10.1002\/ar.21116"},{"key":"key-10.14336\/AD.2020.0216-44","doi-asserted-by":"crossref","unstructured":"Quintas A, de Solis AJ, Diez-Guerra FJ, Carrascosa JM, Bogonez E (2012). Age-associated decrease of SIRT1 expression in rat hippocampus: prevention by late onset caloric restriction. Exp Gerontol, 47:198-201.","DOI":"10.1016\/j.exger.2011.11.010"},{"key":"key-10.14336\/AD.2020.0216-45","doi-asserted-by":"crossref","unstructured":"Pallas M, Pizarro JG, Gutierrez-Cuesta J, Crespo-Biel N, Alvira D, Tajes M, et al. (2008). Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience, 154:1388-1397.","DOI":"10.1016\/j.neuroscience.2008.04.065"},{"key":"key-10.14336\/AD.2020.0216-46","doi-asserted-by":"crossref","unstructured":"Singh P, Hanson PS, Morris CM (2017). SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson's disease. BMC Neurosci, 18:46.","DOI":"10.1186\/s12868-017-0364-1"},{"key":"key-10.14336\/AD.2020.0216-47","doi-asserted-by":"crossref","unstructured":"Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, et al. (2014). Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol, 112:24-49.","DOI":"10.1016\/j.pneurobio.2013.10.004"},{"key":"key-10.14336\/AD.2020.0216-48","doi-asserted-by":"crossref","unstructured":"Moulis M, Vindis C (2018). Autophagy in metabolic age-related human diseases. Cells, 7.","DOI":"10.3390\/cells7100149"},{"key":"key-10.14336\/AD.2020.0216-49","doi-asserted-by":"crossref","unstructured":"Jiang W, Zhang X, Hao J, Shen J, Fang J, Dong W, et al. (2014). SIRT1 protects against apoptosis by promoting autophagy in degenerative human disc nucleus pulposus cells. Sci Rep, 4:7456.","DOI":"10.1038\/srep07456"},{"key":"key-10.14336\/AD.2020.0216-50","doi-asserted-by":"crossref","unstructured":"Miyazaki S, Kakutani K, Yurube T, Maeno K, Takada T, Zhang Z, et al. (2015). Recombinant human SIRT1 protects against nutrient deprivation-induced mitochondrial apoptosis through autophagy induction in human intervertebral disc nucleus pulposus cells. Arthritis Res Ther, 17:253.","DOI":"10.1186\/s13075-015-0763-6"},{"key":"key-10.14336\/AD.2020.0216-51","doi-asserted-by":"crossref","unstructured":"Jeong JK, Moon MH, Lee YJ, Seol JW, Park SY (2013). Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity. Neurobiol Aging, 34:146-156.","DOI":"10.1016\/j.neurobiolaging.2012.04.002"},{"key":"key-10.14336\/AD.2020.0216-52","doi-asserted-by":"crossref","unstructured":"Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, et al. (2011). Resveratrol-activated AMPK\/SIRT1\/autophagy in cellular models of Parkinson's disease. Neurosignals, 19:163-174.","DOI":"10.1159\/000328516"},{"key":"key-10.14336\/AD.2020.0216-53","doi-asserted-by":"crossref","unstructured":"Guo YJ, Dong SY, Cui XX, Feng Y, Liu T, Yin M, et al. (2016). Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of alpha-synuclein via SIRT1-deacetylated LC3. Mol Nutr Food Res, 60:2161-2175.","DOI":"10.1002\/mnfr.201600111"},{"key":"key-10.14336\/AD.2020.0216-54","doi-asserted-by":"crossref","unstructured":"Li SJ, Liu CH, Chang CW, Chu HP, Chen KJ, Mersmann HJ, et al. (2015). Development of a dietary-induced metabolic syndrome model using miniature pigs involvement of AMPK and SIRT1. Eur J Clin Invest, 45:70-80.","DOI":"10.1111\/eci.12370"},{"key":"key-10.14336\/AD.2020.0216-55","doi-asserted-by":"crossref","unstructured":"Lan F, Cacicedo JM, Ruderman N, Ido Y (2008). SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem, 283:27628-27635.","DOI":"10.1074\/jbc.M805711200"},{"key":"key-10.14336\/AD.2020.0216-56","doi-asserted-by":"crossref","unstructured":"Maiese K (2016). Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol, 82:1245-1266.","DOI":"10.1111\/bcp.12804"},{"key":"key-10.14336\/AD.2020.0216-57","doi-asserted-by":"crossref","unstructured":"Feng Y, Liu T, Dong SY, Guo YJ, Jankovic J, Xu H, et al. (2015). Rotenone affects p53 transcriptional activity and apoptosis via targeting SIRT1 and H3K9 acetylation in SH-SY5Y cells. J Neurochem, 134:668-676.","DOI":"10.1111\/jnc.13172"},{"key":"key-10.14336\/AD.2020.0216-58","doi-asserted-by":"crossref","unstructured":"Wang P, Guan YF, Du H, Zhai QW, Su DF, Miao CY (2012). Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyl-transferase in cerebral ischemia. Autophagy, 8:77-87.","DOI":"10.4161\/auto.8.1.18274"},{"key":"key-10.14336\/AD.2020.0216-59","doi-asserted-by":"crossref","unstructured":"Banreti A, Sass M, Graba Y (2013). The emerging role of acetylation in the regulation of autophagy. Autophagy, 9:819-829.","DOI":"10.4161\/auto.23908"},{"key":"key-10.14336\/AD.2020.0216-60","doi-asserted-by":"crossref","unstructured":"Maiese K (2017). Forkhead transcription factors: formulating a FOXO target for cognitive loss. Curr Neurovasc Res, 14:415-420.","DOI":"10.2174\/1567202614666171116102911"},{"key":"key-10.14336\/AD.2020.0216-61","doi-asserted-by":"crossref","unstructured":"Elbaz EM, Senousy MA, El-Tanbouly DM, Sayed RH (2018). Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK\/SIRT1 and JAK2\/STAT3\/NF-kappaB signalling pathway modulation. Toxicol Appl Pharmacol, 352:153-161.","DOI":"10.1016\/j.taap.2018.05.035"},{"key":"key-10.14336\/AD.2020.0216-62","doi-asserted-by":"crossref","unstructured":"Yang SR, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I (2007). Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA\/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol, 292:L567-576.","DOI":"10.1152\/ajplung.00308.2006"},{"key":"key-10.14336\/AD.2020.0216-63","doi-asserted-by":"crossref","unstructured":"Kubota H (2009). Quality control against misfolded proteins in the cytosol: a network for cell survival. J Biochem, 146:609-616.","DOI":"10.1093\/jb\/mvp139"},{"key":"key-10.14336\/AD.2020.0216-64","doi-asserted-by":"crossref","unstructured":"Rodriguez L, Marano MM, Tandon A (2018). Import and export of misfolded alpha-synuclein. Front Neurosci, 12:344.","DOI":"10.3389\/fnins.2018.00344"},{"key":"key-10.14336\/AD.2020.0216-65","doi-asserted-by":"crossref","unstructured":"Jacob P, Hirt H, Bendahmane A (2017). The heat-shock protein\/chaperone network and multiple stress resistance. Plant Biotechnol J, 15:405-414.","DOI":"10.1111\/pbi.12659"},{"key":"key-10.14336\/AD.2020.0216-66","doi-asserted-by":"crossref","unstructured":"Huang C, Wu J, Xu L, Wang J, Chen Z, Yang R (2018). Regulation of HSF1 protein stabilization: an updated review. Eur J Pharmacol, 822:69-77.","DOI":"10.1016\/j.ejphar.2018.01.005"},{"key":"key-10.14336\/AD.2020.0216-67","doi-asserted-by":"crossref","unstructured":"Wang N, Zhang F, Yang L, Zou J, Wang H, Liu K, et al. (2017). Resveratrol protects against L-arginine-induced acute necrotizing pancreatitis in mice by enhancing SIRT1-mediated deacetylation of p53 and heat shock factor 1. Int J Mol Med, 40:427-437.","DOI":"10.3892\/ijmm.2017.3012"},{"key":"key-10.14336\/AD.2020.0216-68","doi-asserted-by":"crossref","unstructured":"Zelin E, Freeman BC (2015). Lysine deacetylases regulate the heat shock response including the age-associated impairment of HSF1. J Mol Biol, 427:1644-1654.","DOI":"10.1016\/j.jmb.2015.02.010"},{"key":"key-10.14336\/AD.2020.0216-69","doi-asserted-by":"crossref","unstructured":"Raynes R, Leckey BD Jr, Nguyen K, Westerheide SD (2012). Heat shock and caloric restriction have a synergistic effect on the heat shock response in a sir2.1-dependent manner in Caenorhabditis elegans. J Biol Chem, 287:29045-29053.","DOI":"10.1074\/jbc.M112.353714"},{"key":"key-10.14336\/AD.2020.0216-70","doi-asserted-by":"crossref","unstructured":"Westerheide SD, Anckar J, Stevens SM Jr, Sistonen L, Morimoto RI (2009). Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science, 323:1063-1066.","DOI":"10.1126\/science.1165946"},{"key":"key-10.14336\/AD.2020.0216-71","doi-asserted-by":"crossref","unstructured":"Wang H, Dong X, Liu Z, Zhu S, Liu H, Fan W, et al. (2018). Resveratrol suppresses rotenone-induced neurotoxicity through activation of SIRT1\/Akt1 signaling pathway. Anat Rec (Hoboken), 301:1115-1125.","DOI":"10.1002\/ar.23781"},{"key":"key-10.14336\/AD.2020.0216-72","doi-asserted-by":"crossref","unstructured":"Liu T, Ma X, Ouyang T, Chen H, Lin J, Liu J, et al. (2018). SIRT1 reverses senescence via enhancing autophagy and attenuates oxidative stress-induced apoptosis through promoting p53 degradation. Int J Biol Macromol, 117:225-234.","DOI":"10.1016\/j.ijbiomac.2018.05.174"},{"key":"key-10.14336\/AD.2020.0216-73","doi-asserted-by":"crossref","unstructured":"Zhang W, Wu H, Yang M, Ye S, Li L, Zhang H, et al. (2016). SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells. Oncotarget, 7:13538-13550.","DOI":"10.18632\/oncotarget.6455"},{"key":"key-10.14336\/AD.2020.0216-74","doi-asserted-by":"crossref","unstructured":"Yu W, Li L, Wang G, Zhang W, Xu J, Liang A (2018). KU70 inhibition impairs both non-homologous end joining and homologous recombination DNA damage repair through SHP-1 induced dephosphorylation of SIRT1 in T-cell acute lymphoblastic leukemia (T-ALL) [corrected]. Cell Physiol Biochem, 49:2111-2123.","DOI":"10.1159\/000493815"},{"key":"key-10.14336\/AD.2020.0216-75","doi-asserted-by":"crossref","unstructured":"Anekonda TS, Adamus G (2008). Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70. BMC Res Notes, 1:122.","DOI":"10.1186\/1756-0500-1-122"},{"key":"key-10.14336\/AD.2020.0216-76","doi-asserted-by":"crossref","unstructured":"Ortiz GG, Pacheco Moises FP, Mireles-Ramirez M, Flores-Alvarado LJ, Gonzalez-Usigli H, Sanchez-Gonzalez VJ, et al. (2017). Oxidative stress: love and hate history in central nervous system. Adv Protein Chem Struct Biol, 108:1-31.","DOI":"10.1016\/bs.apcsb.2017.01.003"},{"key":"key-10.14336\/AD.2020.0216-77","doi-asserted-by":"crossref","unstructured":"Lv J, Jiang S, Yang Z, Hu W, Wang Z, Li T, et al. (2018). PGC-1alpha sparks the fire of neuroprotection against neurodegenerative disorders. Ageing Res Rev, 44:8-21.","DOI":"10.1016\/j.arr.2018.03.004"},{"key":"key-10.14336\/AD.2020.0216-78","doi-asserted-by":"crossref","unstructured":"Uldry M, Yang W, St-Pierre J, Lin J, Seale P, Spiegelman BM (2006). Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab, 3:333-341.","DOI":"10.1016\/j.cmet.2006.04.002"},{"key":"key-10.14336\/AD.2020.0216-79","doi-asserted-by":"crossref","unstructured":"Lerin C, Rodgers JT, Kalume DE, Kim SH, Pandey A, Puigserver P (2006). GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab, 3:429-438.","DOI":"10.1016\/j.cmet.2006.04.013"},{"key":"key-10.14336\/AD.2020.0216-80","doi-asserted-by":"crossref","unstructured":"Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, et al. (2007). Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1alpha. EMBO J, 26:1913-1923.","DOI":"10.1038\/sj.emboj.7601633"},{"key":"key-10.14336\/AD.2020.0216-81","doi-asserted-by":"crossref","unstructured":"Kaur K, Gill JS, Bansal PK, Deshmukh R (2017). Neuroinflammation - a major cause for striatal dopaminergic degeneration in Parkinson's disease. J Neurol Sci, 381:308-314.","DOI":"10.1016\/j.jns.2017.08.3251"},{"key":"key-10.14336\/AD.2020.0216-82","doi-asserted-by":"crossref","unstructured":"Wang Q, Liu Y, Zhou J (2015). Neuroinflammation in Parkinson's disease and its potential as therapeutic target. Transl Neurodegener, 4:19.","DOI":"10.1186\/s40035-015-0042-0"},{"key":"key-10.14336\/AD.2020.0216-83","doi-asserted-by":"crossref","unstructured":"Holmes S, Singh M, Su C, Cunningham RL (2016). Effects of oxidative stress and testosterone on pro-inflammatory signaling in a female rat dopaminergic neuronal cell line. Endocrinology, 157:2824-2835.","DOI":"10.1210\/en.2015-1738"},{"key":"key-10.14336\/AD.2020.0216-84","doi-asserted-by":"crossref","unstructured":"Wee Yong V (2010). Inflammation in neurological disorders: a help or a hindrance? Neuroscientist, 16:408-420.","DOI":"10.1177\/1073858410371379"},{"key":"key-10.14336\/AD.2020.0216-85","doi-asserted-by":"crossref","unstructured":"Leszek J, Barreto GE, Gasiorowski K, Koutsouraki E, Avila-Rodrigues M, Aliev G (2016). Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: role of brain innate immune system. CNS Neurol Disord Drug Targets, 15:329-336.","DOI":"10.2174\/1871527315666160202125914"},{"key":"key-10.14336\/AD.2020.0216-86","doi-asserted-by":"crossref","unstructured":"Ye J, Liu Z, Wei J, Lu L, Huang Y, Luo L, et al. (2013). Protective effect of SIRT1 on toxicity of microglial-derived factors induced by LPS to PC12 cells via the p53-caspase-3-dependent apoptotic pathway. Neurosci Lett, 553:72-77.","DOI":"10.1016\/j.neulet.2013.08.020"},{"key":"key-10.14336\/AD.2020.0216-87","doi-asserted-by":"crossref","unstructured":"Cho SH, Chen JA, Sayed F, Ward ME, Gao F, Nguyen TA, et al. (2015). SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1beta. J Neurosci, 35:807-818.","DOI":"10.1523\/JNEUROSCI.2939-14.2015"},{"key":"key-10.14336\/AD.2020.0216-88","doi-asserted-by":"crossref","unstructured":"Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshima T, et al. (2005). Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol, 5:185-193.","DOI":"10.1016\/j.intimp.2004.08.008"},{"key":"key-10.14336\/AD.2020.0216-89","doi-asserted-by":"crossref","unstructured":"Zhang A, Wang H, Qin X, Pang S, Yan B (2012). Genetic analysis of SIRT1 gene promoter in sporadic Parkinson's disease. Biochem Biophys Res Commun, 422:693-696.","DOI":"10.1016\/j.bbrc.2012.05.059"},{"key":"key-10.14336\/AD.2020.0216-90","doi-asserted-by":"crossref","unstructured":"Jesus S, Gomez-Garre P, Carrillo F, Caceres-Redondo MT, Huertas-Fernandez I, Bernal-Bernal I, et al. (2013). Genetic association of sirtuin genes and Parkinson's disease. J Neurol, 260:2237-2241.","DOI":"10.1007\/s00415-013-6970-7"},{"key":"key-10.14336\/AD.2020.0216-91","doi-asserted-by":"crossref","unstructured":"Yang XD, Qian YW, Xu SQ, Wan DY, Sun FH, Chen SD, et al. (2018). Expression of the gene coding for PGC-1alpha in peripheral blood leukocytes and related gene variants in patients with Parkinson's disease. Parkinsonism Relat Disord, 51:30-35.","DOI":"10.1016\/j.parkreldis.2018.02.037"},{"key":"key-10.14336\/AD.2020.0216-92","doi-asserted-by":"crossref","unstructured":"Hohman TJ, Bush WS, Jiang L, Brown-Gentry KD, Torstenson ES, Dudek SM, et al. (2016). Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer disease genetics consortium. Neurobiol Aging, 38:141-150.","DOI":"10.1016\/j.neurobiolaging.2015.10.031"},{"key":"key-10.14336\/AD.2020.0216-93","doi-asserted-by":"crossref","unstructured":"Kilic U, Gok O, Erenberk U, Dundaroz MR, Torun E, Kucukardali Y, et al. (2015). A remarkable age-related increase in SIRT1 protein expression against oxidative stress in elderly: SIRT1 gene variants and longevity in human. PLoS One, 10:e0117954.","DOI":"10.1371\/journal.pone.0117954"},{"key":"key-10.14336\/AD.2020.0216-94","doi-asserted-by":"crossref","unstructured":"Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, et al. (2002). Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res, 958:439-447.","DOI":"10.1016\/S0006-8993(02)03543-6"},{"key":"key-10.14336\/AD.2020.0216-95","doi-asserted-by":"crossref","unstructured":"Robb EL, Stuart JA (2010). trans-Resveratrol as a neuroprotectant. Molecules, 15:1196-1212.","DOI":"10.3390\/molecules15031196"},{"key":"key-10.14336\/AD.2020.0216-96","doi-asserted-by":"crossref","unstructured":"Albani D, Polito L, Batelli S, De Mauro S, Fracasso C, Martelli G, et al. (2009). The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J Neurochem, 110:1445-1456.","DOI":"10.1111\/j.1471-4159.2009.06228.x"},{"key":"key-10.14336\/AD.2020.0216-97","doi-asserted-by":"crossref","unstructured":"Lee MK, Kang SJ, Poncz M, Song KJ, Park KS (2007). Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Exp Mol Med, 39:376-384.","DOI":"10.1038\/emm.2007.42"},{"key":"key-10.14336\/AD.2020.0216-98","doi-asserted-by":"crossref","unstructured":"Alvira D, Yeste-Velasco M, Folch J, Verdaguer E, Canudas AM, Pallas M, et al. (2007). Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience, 147:746-756.","DOI":"10.1016\/j.neuroscience.2007.04.029"},{"key":"key-10.14336\/AD.2020.0216-99","doi-asserted-by":"crossref","unstructured":"Bournival J, Quessy P, Martinoli MG (2009). Protective effects of resveratrol and quercetin against MPP+ -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol, 29:1169-1180.","DOI":"10.1007\/s10571-009-9411-5"},{"key":"key-10.14336\/AD.2020.0216-100","doi-asserted-by":"crossref","unstructured":"Lin TK, Chen SD, Chuang YC, Lin HY, Huang CR, Chuang JH, et al. (2014). Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy. Int J Mol Sci, 15:1625-1646.","DOI":"10.3390\/ijms15011625"},{"key":"key-10.14336\/AD.2020.0216-101","doi-asserted-by":"crossref","unstructured":"Anandhan A, Tamilselvam K, Vijayraja D, Ashokkumar N, Rajasankar S, Manivasagam T (2010). Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice. Ann Neurosci, 17:113-119.","DOI":"10.5214\/ans.0972-7531.1017304"},{"key":"key-10.14336\/AD.2020.0216-102","doi-asserted-by":"crossref","unstructured":"Blanchet J, Longpre F, Bureau G, Morissette M, DiPaolo T, Bronchti G, et al. (2008). Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice. Prog Neuropsychopharmacol Biol Psychiatry, 32:1243-1250.","DOI":"10.1016\/j.pnpbp.2008.03.024"},{"key":"key-10.14336\/AD.2020.0216-103","doi-asserted-by":"crossref","unstructured":"Lu KT, Ko MC, Chen BY, Huang JC, Hsieh CW, Lee MC, et al. (2008). Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem, 56:6910-6913.","DOI":"10.1021\/jf8007212"},{"key":"key-10.14336\/AD.2020.0216-104","doi-asserted-by":"crossref","unstructured":"Wang Y, Xu H, Fu Q, Ma R, Xiang J (2011). Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in parkinsonian rats. J Neurol Sci, 304:29-34.","DOI":"10.1016\/j.jns.2011.02.025"},{"key":"key-10.14336\/AD.2020.0216-105","doi-asserted-by":"crossref","unstructured":"Ferretta A, Gaballo A, Tanzarella P, Piccoli C, Capitanio N, Nico B, et al. (2014). Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease. Biochim Biophys Acta, 1842:902-915.","DOI":"10.1016\/j.bbadis.2014.02.010"},{"key":"key-10.14336\/AD.2020.0216-106","doi-asserted-by":"crossref","unstructured":"Smoliga JM, Vang O, Baur JA (2012). Challenges of translating basic research into therapeutics: resveratrol as an example. J Gerontol A Biol Sci Med Sci, 67:158-167.","DOI":"10.1093\/gerona\/glr062"},{"key":"key-10.14336\/AD.2020.0216-107","doi-asserted-by":"crossref","unstructured":"Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425:191-196.","DOI":"10.1038\/nature01960"},{"key":"key-10.14336\/AD.2020.0216-108","doi-asserted-by":"crossref","unstructured":"Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, et al. (2007). Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature, 450:712-716.","DOI":"10.1038\/nature06261"},{"key":"key-10.14336\/AD.2020.0216-109","doi-asserted-by":"crossref","unstructured":"Kasiotis KM, Pratsinis H, Kletsas D, Haroutounian SA (2013). Resveratrol and related stilbenes: their anti-aging and anti-angiogenic properties. Food Chem Toxicol, 61:112-120.","DOI":"10.1016\/j.fct.2013.03.038"},{"key":"key-10.14336\/AD.2020.0216-110","doi-asserted-by":"crossref","unstructured":"Riviere C, Pawlus AD, Merillon JM (2012). Natural stilbenoids: distribution in the plant kingdom and chemotaxonomic interest in Vitaceae. Nat Prod Rep, 29:1317-1333.","DOI":"10.1039\/c2np20049j"},{"key":"key-10.14336\/AD.2020.0216-111","doi-asserted-by":"crossref","unstructured":"Temsamani H, Krisa S, Decossas-Mendoza M, Lambert O, M\u00e9rillon JM, Richard T (2016). Piceatannol and other wine stilbenes: a pool of inhibitors against \u03b1-synuclein aggregation and cytotoxicity. Nutrients, 8.","DOI":"10.3390\/nu8060367"},{"key":"key-10.14336\/AD.2020.0216-112","doi-asserted-by":"crossref","unstructured":"Nishida K, Matsushita T, Takayama K, Tanaka T, Miyaji N, Ibaraki K, et al. (2018). Intraperitoneal injection of the SIRT1 activator SRT1720 attenuates the progression of experimental osteoarthritis in mice. Bone Joint Res, 7:252-262.","DOI":"10.1302\/2046-3758.73.BJR-2017-0227.R1"},{"key":"key-10.14336\/AD.2020.0216-113","doi-asserted-by":"crossref","unstructured":"Opal SM, Ellis JL, Suri V, Freudenberg JM, Vlasuk GP, Li Y, et al. (2016). Pharmacological SIRT1 activation improves mortality and markedly alters transcriptional profiles that accompany experimental sepsis. Shock, 45:411-418.","DOI":"10.1097\/SHK.0000000000000528"},{"key":"key-10.14336\/AD.2020.0216-114","doi-asserted-by":"crossref","unstructured":"Mitchell SJ, Martin-Montalvo A, Mercken EM, Palacios HH, Ward TM, Abulwerdi G, et al. (2014). The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep, 6:836-843.","DOI":"10.1016\/j.celrep.2014.01.031"},{"key":"key-10.14336\/AD.2020.0216-115","doi-asserted-by":"crossref","unstructured":"Miranda MX, van Tits LJ, Lohmann C, Arsiwala T, Winnik S, Tailleux A, et al. (2015). The SIRT1 activator SRT3025 provides atheroprotection in Apoe-\/- mice by reducing hepatic Pcsk9 secretion and enhancing LDLR expression. Eur Heart J, 36:51-59.","DOI":"10.1093\/eurheartj\/ehu095"},{"key":"key-10.14336\/AD.2020.0216-116","doi-asserted-by":"crossref","unstructured":"Graff J, Kahn M, Samiei A, Gao J, Ota KT, Rei D, et al. (2013). A dietary regimen of caloric restriction or pharmacological activation of SIRT1 to delay the onset of neurodegeneration. J Neurosci, 33:8951-8960.","DOI":"10.1523\/JNEUROSCI.5657-12.2013"},{"key":"key-10.14336\/AD.2020.0216-117","doi-asserted-by":"crossref","unstructured":"Liu P, Feng T, Zuo X, Wang X, Luo J, Li N, et al. (2018). A novel SIRT1 activator E6155 improves insulin sensitivity in type 2 diabetic KKAy mice. Biochem Biophys Res Commun, 498:633-639.","DOI":"10.1016\/j.bbrc.2018.03.034"},{"key":"key-10.14336\/AD.2020.0216-118","doi-asserted-by":"crossref","unstructured":"Zordoky BN, Robertson IM, Dyck JR (2015). Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta, 1852:1155-1177.","DOI":"10.1016\/j.bbadis.2014.10.016"},{"key":"key-10.14336\/AD.2020.0216-119","doi-asserted-by":"crossref","unstructured":"Agarwal B, Campen MJ, Channell MM, Wherry SJ, Varamini B, Davis JG, et al. (2013). Resveratrol for primary prevention of atherosclerosis: clinical trial evidence for improved gene expression in vascular endothelium. Int J Cardiol, 166:246-248.","DOI":"10.1016\/j.ijcard.2012.09.027"},{"key":"key-10.14336\/AD.2020.0216-120","doi-asserted-by":"crossref","unstructured":"Seyyedebrahimi S, Khodabandehloo H, Nasli Esfahani E, Meshkani R (2018). The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Acta Diabetol, 55:341-353.","DOI":"10.1007\/s00592-017-1098-3"},{"key":"key-10.14336\/AD.2020.0216-121","doi-asserted-by":"crossref","unstructured":"Pennisi M, Bertino G, Gagliano C, Malaguarnera M, Bella R, Borzi AM, et al. (2017). Resveratrol in hepatitis C patients treated with pegylated-interferon-alpha-2b and ribavirin reduces sleep disturbance. Nutrients, 9.","DOI":"10.3390\/nu9080897"},{"key":"key-10.14336\/AD.2020.0216-122","doi-asserted-by":"crossref","unstructured":"Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, et al. (2017). Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. J Neuroinflammation, 14:1.","DOI":"10.1186\/s12974-016-0779-0"},{"key":"key-10.14336\/AD.2020.0216-123","doi-asserted-by":"crossref","unstructured":"Banaszewska B, Wrotynska-Barczynska J, Spaczynski RZ, Pawelczyk L, Duleba AJ (2016). Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab, 101:4322-4328.","DOI":"10.1210\/jc.2016-1858"},{"key":"key-10.14336\/AD.2020.0216-124","doi-asserted-by":"crossref","unstructured":"Baksi A, Kraydashenko O, Zalevkaya A, Stets R, Elliott P, Haddad J, et al. (2014). A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes. Br J Clin Pharmacol, 78:69-77.","DOI":"10.1111\/bcp.12327"},{"key":"key-10.14336\/AD.2020.0216-125","doi-asserted-by":"crossref","unstructured":"Sands BE, Joshi S, Haddad J, Freudenberg JM, Oommen DE, Hoffmann E, et al. (2016). Assessing colonic exposure, safety, and clinical activity of SRT2104, a novel oral SIRT1 activator, in patients with mild to moderate ulcerative colitis. Inflamm Bowel Dis, 22:607-614.","DOI":"10.1097\/MIB.0000000000000597"},{"key":"key-10.14336\/AD.2020.0216-126","doi-asserted-by":"crossref","unstructured":"Krueger JG, Suarez-Farinas M, Cueto I, Khacherian A, Matheson R, Parish LC, et al. (2015). A randomized, placebo-controlled study of SRT2104, a SIRT1 activator, in patients with moderate to severe psoriasis. PLoS One, 10:e0142081.","DOI":"10.1371\/journal.pone.0142081"},{"key":"key-10.14336\/AD.2020.0216-127","doi-asserted-by":"crossref","unstructured":"Venkatasubramanian S, Noh RM, Daga S, Langrish JP, Joshi NV, Mills NL, et al. (2013). Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokers. J Am Heart Assoc, 2:e000042.","DOI":"10.1161\/JAHA.113.000042"},{"key":"key-10.14336\/AD.2020.0216-128","doi-asserted-by":"crossref","unstructured":"Voorhees JR, Remy MT, Cintron-Perez CJ, El Rassi E, Khan MZ, Dutca LM, et al. (2018). (-)-P7C3-S243 protects a rat model of Alzheimer's disease from neuropsychiatric deficits and neurodegeneration without altering amyloid deposition or reactive glia. Biol Psychiatry, 84:488-498.","DOI":"10.1016\/j.biopsych.2017.10.023"},{"key":"key-10.14336\/AD.2020.0216-129","doi-asserted-by":"crossref","unstructured":"Tesla R, Wolf HP, Xu P, Drawbridge J, Estill SJ, Huntington P, et al. (2012). Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A, 109:17016-17021.","DOI":"10.1073\/pnas.1213960109"},{"key":"key-10.14336\/AD.2020.0216-130","doi-asserted-by":"crossref","unstructured":"Blaya MO, Wasserman JM, Pieper AA, Sick TJ, Bramlett HM, Dietrich WD (2018). Neurotherapeutic Capacity of P7C3 Agents for the Treatment of Traumatic Brain Injury. Neuropharmacology.","DOI":"10.1016\/j.neuropharm.2018.09.024"},{"key":"key-10.14336\/AD.2020.0216-131","doi-asserted-by":"crossref","unstructured":"Zhang LQ, Nsumu M, Huang P, Heruth DP, Riordan SM, Shortt K, et al. (2018). Novel protective role of nicotinamide phosphoribosyltransferase in acetaminophen-induced acute liver injury in mice. Am J Pathol, 188:1640-1652.","DOI":"10.1016\/j.ajpath.2018.04.004"},{"key":"key-10.14336\/AD.2020.0216-132","doi-asserted-by":"crossref","unstructured":"Oku H, Morishita S, Horie T, Nishikawa Y, Kida T, Mimura M, et al. (2017). Protective effect of P7C3 on retinal ganglion cells from optic nerve injury. Jpn J Ophthalmol, 61:195-203.","DOI":"10.1007\/s10384-016-0493-6"},{"key":"key-10.14336\/AD.2020.0216-133","doi-asserted-by":"crossref","unstructured":"Wang SN, Xu TY, Wang X, Guan YF, Zhang SL, Wang P, et al. (2016). Neuroprotective efficacy of an aminopropyl carbazole derivative P7C3-A20 in ischemic stroke. CNS Neurosci Ther, 22:782-788.","DOI":"10.1111\/cns.12576"},{"key":"key-10.14336\/AD.2020.0216-134","doi-asserted-by":"crossref","unstructured":"Rajman L, Chwalek K, Sinclair DA (2018). Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab, 27:529-547.","DOI":"10.1016\/j.cmet.2018.02.011"},{"key":"key-10.14336\/AD.2020.0216-135","doi-asserted-by":"crossref","unstructured":"Anderson RM, Bitterman KJ, Wood JG, Medvedik O, Sinclair DA (2003). Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature, 423:181-185.","DOI":"10.1038\/nature01578"},{"key":"key-10.14336\/AD.2020.0216-136","doi-asserted-by":"crossref","unstructured":"Gallo CM, Smith DL Jr, Smith JS (2004). Nicotinamide clearance by Pnc1 directly regulates Sir2-mediated silencing and longevity. Mol Cell Biol, 24:1301-1312.","DOI":"10.1128\/MCB.24.3.1301-1312.2004"},{"key":"key-10.14336\/AD.2020.0216-137","doi-asserted-by":"crossref","unstructured":"Yaku K, Okabe K, Nakagawa T (2018). NAD metabolism: implications in aging and longevity. Ageing Res Rev, 47:1-17.","DOI":"10.1016\/j.arr.2018.05.006"},{"key":"key-10.14336\/AD.2020.0216-138","doi-asserted-by":"crossref","unstructured":"Zou XD, Guo SQ, Hu ZW, Li WL (2016). NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity. Mol Med Rep, 13:4058-4064.","DOI":"10.3892\/mmr.2016.5034"},{"key":"key-10.14336\/AD.2020.0216-139","doi-asserted-by":"crossref","unstructured":"Wang G, Han T, Nijhawan D, Theodoropoulos P, Naidoo J, Yadavalli S, et al. (2014). P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage. Cell, 158:1324-1334.","DOI":"10.1016\/j.cell.2014.07.040"},{"key":"key-10.14336\/AD.2020.0216-140","doi-asserted-by":"crossref","unstructured":"De Jesus-Cortes H, Xu P, Drawbridge J, Estill SJ, Huntington P, Tran S, et al. (2012). Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease. Proc Natl Acad Sci U S A, 109:17010-17015.","DOI":"10.1073\/pnas.1213956109"},{"key":"key-10.14336\/AD.2020.0216-141","doi-asserted-by":"crossref","unstructured":"Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444:337-342.","DOI":"10.1038\/nature05354"},{"key":"key-10.14336\/AD.2020.0216-142","doi-asserted-by":"crossref","unstructured":"Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, et al. (2013). Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science, 339:1216-1219.","DOI":"10.1126\/science.1231097"},{"key":"key-10.14336\/AD.2020.0216-143","doi-asserted-by":"crossref","unstructured":"Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, et al. (2010). SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem, 285:8340-8351.","DOI":"10.1074\/jbc.M109.088682"},{"key":"key-10.14336\/AD.2020.0216-144","doi-asserted-by":"crossref","unstructured":"Santos D, Mahoney JR, Allali G, Verghese J (2017). Physical activity in older adults with mild parkinsonian signs: a cohort study. J Gerontol A Biol Sci Med Sci, 73:1682-1687.","DOI":"10.1093\/gerona\/glx133"},{"key":"key-10.14336\/AD.2020.0216-145","doi-asserted-by":"crossref","unstructured":"Hou L, Chen W, Liu X, Qiao D, Zhou FM (2017). Exercise-induced neuroprotection of the nigrostriatal dopamine system in Parkinson's disease. Front Aging Neurosci, 9:358.","DOI":"10.3389\/fnagi.2017.00358"},{"key":"key-10.14336\/AD.2020.0216-146","doi-asserted-by":"crossref","unstructured":"Tuon T, Souza PS, Santos MF, Pereira FT, Pedroso GS, Luciano TF, et al. (2015). Physical training regulates mitochondrial parameters and neuroinflammatory mechanisms in an experimental model of Parkinson's disease. Oxid Med Cell Longev, 2015:261809.","DOI":"10.1155\/2015\/261809"},{"key":"key-10.14336\/AD.2020.0216-147","doi-asserted-by":"crossref","unstructured":"Munoz A, Correa CL, Lopez-Lopez A, Costa-Besada MA, Diaz-Ruiz C, Labandeira-Garcia JL (2018). Physical exercise improves aging-related changes in angiotensin, IGF-1, SIRT 1, SIRT3 and VEGF in the substantia nigra. J Gerontol A Biol Sci Med Sci, 73:1594-1601.","DOI":"10.1093\/gerona\/gly072"},{"key":"key-10.14336\/AD.2020.0216-148","doi-asserted-by":"crossref","unstructured":"Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, et al. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell, 107:149-159.","DOI":"10.1016\/S0092-8674(01)00527-X"},{"key":"key-10.14336\/AD.2020.0216-149","doi-asserted-by":"crossref","unstructured":"Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, et al. (2004). Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science, 305:390-392.","DOI":"10.1126\/science.1099196"},{"key":"key-10.14336\/AD.2020.0216-150","doi-asserted-by":"crossref","unstructured":"Roth M, Wang Z, Chen WY (2016). SIRT1 and LSD1 competitively regulate KU70 functions in DNA repair and mutation acquisition in cancer cells. Oncotarget, 7:50195-50214.","DOI":"10.18632\/oncotarget.10328"},{"key":"key-10.14336\/AD.2020.0216-151","doi-asserted-by":"crossref","unstructured":"Wang R, Li JJ, Diao S, Kwak YD, Liu L, Zhi L, et al. (2013). Metabolic stress modulates Alzheimer's beta-secretase gene transcription via SIRT1-PPARgamma-PGC-1 in neurons. Cell Metab, 17:685-694.","DOI":"10.1016\/j.cmet.2013.03.016"},{"key":"key-10.14336\/AD.2020.0216-152","doi-asserted-by":"crossref","unstructured":"Qiang L, Wang L, Kon N, Zhao W, Lee S, Zhang Y, et al. (2012). Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppargamma. Cell, 150:620-632.","DOI":"10.1016\/j.cell.2012.06.027"},{"key":"key-10.14336\/AD.2020.0216-153","doi-asserted-by":"crossref","unstructured":"Julien C, Tremblay C, Emond V, Lebbadi M, Salem N Jr, Bennett DA, et al. (2009). Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol, 68:48-58.","DOI":"10.1097\/NEN.0b013e3181922348"},{"key":"key-10.14336\/AD.2020.0216-154","doi-asserted-by":"crossref","unstructured":"Min SW, Sohn PD, Li Y, Devidze N, Johnson JR, Krogan NJ, et al. (2018). SIRT1 deacetylates Tau and reduces pathogenic tau spread in a mouse model of tauopathy. J Neurosci, 38:3680-3688.","DOI":"10.1523\/JNEUROSCI.2369-17.2018"},{"key":"key-10.14336\/AD.2020.0216-155","doi-asserted-by":"crossref","unstructured":"Jeong H, Cohen DE, Cui L, Supinski A, Savas JN, Mazzulli JR, et al. (2011). Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med, 18:159-165.","DOI":"10.1038\/nm.2559"},{"key":"key-10.14336\/AD.2020.0216-156","doi-asserted-by":"crossref","unstructured":"Grewal AK, Singh N, Singh TG (2019). Effects of resveratrol postconditioning on cerebral ischemia in mice: role of the sirtuin-1 pathway. Can J Physiol Pharmacol, 97:1094-1101.","DOI":"10.1139\/cjpp-2019-0188"},{"key":"key-10.14336\/AD.2020.0216-157","doi-asserted-by":"crossref","unstructured":"Perrini S, Porro S, Nigro P, Cignarelli A, Caccioppoli C, Genchi VA, et al. (2019). Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity. Int J Obes (Lond), 44:307-319.","DOI":"10.1038\/s41366-019-0436-7"},{"key":"key-10.14336\/AD.2020.0216-158","doi-asserted-by":"crossref","unstructured":"Wu SY, Liang J, Yang BC, Leung PS (2019). SIRT1 activation promotes beta-cell regeneration by activating endocrine progenitor cells via AMPK signaling-mediated fatty acid oxidation. Stem Cells, 37:1416-1428.","DOI":"10.1002\/stem.3073"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aginganddisease.org\/fileup\/2152-5250\/PDF\/ad-0-0-0-2002160802-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:10:42Z","timestamp":1627513842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2020.0216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":158,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2020.0216","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}